Focus: Samsara Vision is a public biotechnology company focused on ophthalmic devices, headquartered in Far Hills, NJ. Founded in 2018, the company operates in a specialized medical device segment within ophthalmology.
Profile data last refreshed 6h ago · AI intelligence enriched 1mo ago
Hot — 394 jobs added in 30d
Net +370 (394 new, 24 removed). Aggressive expansion phase.
Samsara Vision appears to be in a transition or optimization phase; suitable only for candidates with specific ophthalmic device expertise or interest in smaller public company environments.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Samsara Vision
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Samsara Vision's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles